← Leaderboards
David L Bartlett
Clinical Sciences
$7,205,000
Attributed
$8,291,012
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$8,291,012 · 7
By mechanism
R01$4,334,323 · 3
T32$1,880,507 · 1
P01$1,177,359 · 1
R21$519,532 · 1
P30$379,291 · 1
Top collaborators
- Yong J Lee5 shared
- Herbert J Zeh5 shared
Most similar at Clinical Sciences
Same institution · by research overlap
- David Schrump$0
- Antonio Tito Fojo$741,243
- H R Alexander$0
- Antonio Fojo$0
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsClinical TrialsDoseTumorProgramsNovel StrategiesResponseVaccinia VirusColorectal CancerIn VivoImmune ResponseImmuneLeadInterestResearch PersonnelInjection Of Therapeutic AgentGenesNeoplasm MetastasisMutationCancer CellCellsInfectionCancer PatientMediating
Grant awards (40)
Postdoctoral Research Training in Biotherapy of Cancer$193,203
T32 · FY2018 · CA · contact PI
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion$313,159
R01 · FY2015 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$196,206
T32 · FY2015 · CA · contact PI
Multimodality approach to hepatic colorectal metastases$342,780
R01 · FY2014 · CA
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion$303,798
R01 · FY2014 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$182,236
T32 · FY2014 · CA · contact PI
STAFF INVESTIGATORS$55,526
P30 · FY2014 · CA · contact PI
Multimodality approach to hepatic colorectal metastases$336,991
R01 · FY2013 · CA
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion$294,435
R01 · FY2013 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$206,107
P01 · FY2013 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$176,763
T32 · FY2013 · CA · contact PI
STAFF INVESTIGATORS$102,795
P30 · FY2013 · CA · contact PI
Multimodality approach to hepatic colorectal metastases$346,211
R01 · FY2012 · CA
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion$313,262
R01 · FY2012 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$220,658
P01 · FY2012 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$188,321
T32 · FY2012 · CA · contact PI
STAFF INVESTIGATORS$122,401
P30 · FY2012 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$22,938
P01 · FY2012 · CA · contact PI
Multimodality approach to hepatic colorectal metastases$357,804
R01 · FY2011 · CA
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion$313,294
R01 · FY2011 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$238,387
P01 · FY2011 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$174,265
T32 · FY2011 · CA · contact PI
STAFF INVESTIGATORS$48,993
P30 · FY2011 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$247,021
P01 · FY2010 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$245,963
T32 · FY2010 · CA · contact PI
Multimodality approach to hepatic colorectal metastases$245,232
R01 · FY2010 · CA
STAFF INVESTIGATORS$49,576
P30 · FY2010 · CA · contact PI
Tumor-Selective Oncolytic Vaccinia Virus and alphaDC1-Based Vaccine as a Combinat$242,248
P01 · FY2009 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$4,336
T32 · FY2009 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$156,110
T32 · FY2008 · CA · contact PI
Development of a Tumor Selective Replicating Vaccinia$281,646
R01 · FY2007 · CA · contact PI
Isolated Hepatic Perfusion with Oxaliplatin$255,944
R21 · FY2007 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$236,341
T32 · FY2007 · CA · contact PI
Development of a Tumor Selective Replicating Vaccinia$290,267
R01 · FY2006 · CA · contact PI
Islolated Hepatic Perfusion with Oxaliplatin$263,588
R21 · FY2006 · CA · contact PI
Postdoctoral Research Training in Biotherapy of Cancer$126,763
T32 · FY2006 · CA · contact PI
Development of a Tumor Selective Replicating Vaccinia$297,461
R01 · FY2005 · CA
Development of a Tumor Selective Replicating Vaccinia$297,983
R01 · FY2004 · CA
Tumor selective viral vectors and surgical procedures$0
Z01 · FY2001 · SC
Development of tumor selective viral vectors and development of surgical procedu$0
Z01 · FY2000 · SC